Engage Bio
Potent, durable, and redosable non-viral genetic medicines
HealthtechAcquired
Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.
Open Roles
No open roles right now.
Verified Team
No verified team members yet.